fresenius medical care ags fms q2 adjusted operating income increased 41 yy to €401 million the adjusted net income jumped 51 to €175 million revenue increased by 1 to €483 billion in the second quarter 6 at constant currency 6 organic care delivery revenue increased by 1 to €387 billion 6 at constant currency 6 organic in parallel the company continuously executes its operational efficiency and turnaround plans the fme25 transformation program delivered €75 million in additional savings in the second quarter fresenius medical care is fully on track to achieve sustainable savings of €250300 million by yearend 2023 and €650 million by yearend 2025 as expected we have seen a stabilization of the labor market and the inflationary environment our measures to increase productivity supported by the targeted clinic closures are driving a positive development this gives us the confidence to narrow our operating income guidance range to the upper part for the year said helen giza ceo of fresenius medical care guidance fresenius medical care expects 2023 operating income to remain flat or slip by up to a lowsingledigit percentage the company had previously projected earnings to remain flat or decline by up to a highsingledigit percentage rate the companys target to achieve an operating income margin of 1014 by 2025 remains unchanged price action fms shares are down 201 at 2531 on the last check wednesday